Try our Advanced Search for more refined results
April 13, 2012
OSI Pharmaceuticals LLC et al v. Roxane Laboratories Inc.
Case Number:
1:12-cv-00465
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 13, 2012
Astellas Unit, Pfizer Sue To Bar Roxane's Generic Tarceva
Astellas Pharma Inc. unit OSI Pharmaceuticals LLC, Pfizer Inc. and Genentech Inc. on Friday sued Roxane Laboratories Inc. in Delaware federal court over Roxane's bid for approval to market a generic version of the cancer treatment Tarceva.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login